Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 1,879 | 1,191 | 1,107 | 1,067 | 1,889 |
| Cost of Goods | 222 | 231 | 252 | 132 | 223 |
| Gross Profit | 1,657 | 960 | 855 | 935 | 1,666 |
| Operating Expenses | 16,224 | 13,329 | 14,169 | 12,205 | 31,177 |
| Operating Income | -14,344 | -12,138 | -13,062 | -11,138 | -29,288 |
| Interest Expense | 64 | 7 | 10 | 8 | 2 |
| Other Income | -499 | -119 | 165 | 69 | -41 |
| Pre-tax Income | -14,907 | -12,264 | -12,907 | -11,077 | -29,331 |
| Income Tax | -2,201 | -2,313 | -1,513 | -1,349 | N/A |
| Net Income Continuous | -12,706 | -9,951 | -11,394 | -9,728 | -26,050 |
| Minority Interests | -2,181 | -1,683 | -1,874 | -1,629 | -6,438 |
| Net Income | $-10,525 | $-8,268 | $-9,520 | $-8,099 | $-19,611 |
| EPS Basic Total Ops | -0.13 | -0.12 | -0.16 | -0.14 | -0.36 |
| EPS Basic Continuous Ops | -0.16 | -0.15 | -0.19 | -0.17 | -0.47 |
| EPS Diluted Total Ops | -0.13 | -0.12 | -0.16 | -0.14 | -0.36 |
| EPS Diluted Continuous Ops | -0.16 | -0.15 | -0.19 | -0.17 | -0.47 |
| EBITDA(a) | $-10,709 | $-10,503 | $-11,279 | $-9,511 | $-28,352 |